Formations et évènements
ASCO 2025
30 Mai 2025 - 03 Juin 2025
Chicago
L'IFCT à l'ASCO 2025 :
An international, multicenter, prospective randomized trial of adjuvant chemotherapy for stage Ia-IIa non-small cell lung cancer identified as high-risk by a 14-gene molecular assay.
David Spigel
Poster session - ASCO Press Program
Molecular profiling and survival in oncogene-addicted resected stage IIIAN2 non-small cell lung cancer (NSCLC): A study from the Lung ART IFCT 0503 trial.
Victor Albarran-Artahona
Poster session
Pathomics-based prediction of thymic epithelial tumor subtypes within the French RYTHMIC network.
Lodovica Zullo
Poster session